CMS is expected to announce in early 2025 the list of up to 15 Medicare Part D drugs that will be subject to price negotiations in 2025, with negotiated prices expected to be implemented in 2027.

Mylan has become the first company to launch a generic version of GlaxoSmithKline's (GSK) big-selling respiratory drug Seretide in the UK. Seretide (salmeterol xinafoate/fluticasone propionate ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... a long-acting beta2-agonist, in a single inhaler, the Ellipta. Sales of the drug are ...

Doctors could be taught to limit the use of traditional asthma inhalers due to their environmental impact. This initiative, led by the University of Glasgow and coordinated by the European ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it ...

Medically reviewed by Lindsay Cook, PharmDMedically reviewed by Lindsay Cook, PharmD Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

The tobacco giant that makes Marlboro cigarettes has sold a UK inhaler company for a knock-down price due to what it calls an "unwarranted" backlash. Philip Morris International (PMI) has ...

A salt pipe is an inhaler containing salt particles. Advocates of salt pipes suggest they help with many health conditions, including asthma, but scientific support is limited. Salt therapy ...

Tea tree oil is promoted as a treatment for some skin conditions and for its antimicrobial properties. However, it is toxic when taken orally and may cause other unwanted side effects. Share on ...